Celastrol ameliorates cytokine toxicity and pro-inflammatory immune responses by suppressing NF-κB activation in RINm5F beta cells |
Ju, Sung Mi
(Department of Biomedical Science and Research Institute for Bioscience & Biotechnology, Hallym University)
Youn, Gi Soo (Department of Biomedical Science and Research Institute for Bioscience & Biotechnology, Hallym University) Cho, Yoon Shin (Department of Biomedical Science and Research Institute for Bioscience & Biotechnology, Hallym University) Choi, Soo Young (Department of Biomedical Science and Research Institute for Bioscience & Biotechnology, Hallym University) Park, Jinseu (Department of Biomedical Science and Research Institute for Bioscience & Biotechnology, Hallym University) |
1 | Häcker H and Karin M (2006). Regulation and function of IKK and IKKrelated kinases. Sci STKE 2006, re13 DOI ScienceOn |
2 | Park MC, Kim D, Lee Y and Kwon HJ (2013) CD83 expression induced by CpG-DNA stimulation in a macrophage cell line RAW 264.7. BMB Rep 46, 448-453 DOI ScienceOn |
3 | Shin SY, Kim CG and Lee YH (2013) Egr-1 regulates the transcription of the BRCA1 gene by etoposide. BMB Rep 46, 92-96 DOI ScienceOn |
4 | Igoillo-Esteve M, Marselli L, Cunha DA et al (2010) Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 53, 1395-1405 DOI |
5 | Cardozo AK, Heimberg H, Heremans Y et al (2001) A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem 276, 48879-48886 DOI ScienceOn |
6 | Pirot P, Cardozo AK and Eizirik DL (2008) Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes. Arq Bras Endocrinol Metabol 52, 156-165 DOI ScienceOn |
7 | Cameron MJ, Arreaza GA, Grattan M et al (2000) Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J Immunol 165, 1102-1110 DOI |
8 | Zhao Y, Krishnamurthy B, Mollah ZU, Kay TW and Thomas HE (2011) NF-κB in type 1 diabetes. Inflamm Allergy Drug Targets 10, 208-217 DOI |
9 | Lee JH, Koo TH, Yoon H et al (2006) Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. Biochem Pharmacol 72, 1311-1321 DOI ScienceOn |
10 | Kwon DJ, Bae YS, Ju SM, Youn GS, Choi SY and Park J (2014) Salicortin suppresses lipopolysaccharide-stimulated inflammatory responses via blockade of NF-κB and JNK activation in RAW 264.7 macrophages. BMB Rep 47, 318-323 DOI ScienceOn |
11 | Youn GS, Kwon DJ, Ju SM, Choi SY and Park J (2013) Curcumin ameliorates TNF-α-induced ICAM-1 expression and subsequent THP-1 adhesiveness via the induction of heme oxygenase-1 in the HaCaT cells. BMB Rep 46, 410-415 DOI ScienceOn |
12 | Chen MC, Proost P, Gysemans C, Mathieu C and Eizirik DL (2001) Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia 44, 325-332 DOI |
13 | Sarkar SA, Lee CE, Victorino F et al (2012) Expression and regulation of chemokines in murine and human type 1 diabetes. Diabetes 61, 436-446 DOI |
14 | Karin M and Delhase M (2000) The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signaling. Semin Immunol 12, 85-98 DOI ScienceOn |
15 | Kim JE, Lee MH, Nam DH et al (2013) Celastrol, an NF-κB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice. PLoS One 8, e62068 DOI |
16 | Allison AC, Cacabelos R, Lombardi VR, Alvarez XA and Vigo C (2001) Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 25, 1341-1357 DOI ScienceOn |
17 | Kannaiyan R, Shanmugam MK and Sethi G (2011) Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer. Cancer Lett 303, 9-20 DOI ScienceOn |
18 | Grant CW, Moran-Paul CM, Duclos SK, Guberski DL, Arreaza-Rubín G and Spain LM (2013) Testing Agents for Prevention or Reversal of Type 1 Diabetes in Rodents. PLoS One 8, e72989 DOI |
19 | Corbett JA and McDaniel ML (1992) Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes 41, 897-903 DOI |
20 | Eizirik DL, Colli ML and Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5, 219-226 DOI ScienceOn |
21 | Holohan C, Szegezdi E, Ritter T, O'Brien T and Samali A (2008) Cytokine-induced beta-cell apoptosis is NO-dependent, mitochondria-mediated and inhibited by BCL-XL. J Cell Mol Med 12, 591-606 DOI ScienceOn |
22 | Rabinovitch A and Suarez-Pinzon WL (1998) Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 55, 1139-1149 DOI ScienceOn |
23 | Eizirik DL and Mandrup-Poulsen T (2001) A choice of death-- the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44, 2115-2133 DOI |
24 | Southern C, Schulster D and Green IC (1990) Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 276, 42-44 DOI ScienceOn |
![]() |